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Background: Lymphomas are common malignancies that have various subtypes with many overlapping histologic,
immunophenotypic and genetic features. Therefore, discordance in classifying lymphoma among pathologists may
be encountered. But this issue is not well characterized. We conducted the present study to demonstrate
discordances among Thai hematopathologists as well as to highlight common arguing points for classifying
lymphomas.
Methods: The 117 lymphoma cases were randomly retrieved and individually reviewed by 7 hematopathologists,
members of the “Thai Hematopathologist Group,” without knowing the original diagnoses. The consensus
diagnoses were given from a discussion by all members. In each case, the diagnosis from each participant was
compared with the consensus diagnosis and classified into 4 categories as follow: 1) concordance, 2) minor
discordance, 3) major discordance and 4) serious discordance.
Results: There were approximately 11% discordances between original and consensus diagnoses. The average
discordances among all pathologists according to minor, major and serious discordances were 10%, 3.5% and 0.3%,
respectively. Diffuse large B-cell lymphoma had the least discordance (7%). Small biopsies had been found to
increase discordances in some lymphoma subtypes.
Conclusions: The present study reveals some degrees of interobserver variation in classifying of lymphoma by
using the 2008 WHO classification among hematopathologists. Some types of lymphomas on small biopsies were
found to have a significant higher discordance rate. This study also described some common diagnostic
discordances regarded as potential pitfalls in classifying lymphomas.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/13000_2014_162
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Lymphomas are common malignancies worldwide. Due
to the advances in immunology and genetic technolo-
gies, classification of lymphoma has been regularly up-
dated [1,2]. In the current WHO classification published
in 2008, clinical features, histopathology, immunopheno-
type and genetic features are important to classify lymph-
omas [1,2]. Since, there were >30 lymphoma subtypes in* Correspondence: pongsak.w@chula.ac.th
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article, unless otherwise stated.the 2001 version and >60 in the 2008 version. Such many
entities have increased the overlapping clinicopathologic
features thus may increase difficulty in classifying lymph-
omas. As previously reported, approximately 10% of T-cell
lymphomas were either misdiagnosed or inadequately
subclassified by world expert hematopathologists [3].
Interobserver variation as well as pitfalls in classifying
all lymphoma subtypes according to the WHO classifica-
tion among hematopathologists has not been well docu-
mented. We hereby conducted this study to address this
issue by allowing 7 Thai hematopathologists, members
of the “Thai Hematopathologist Group”, to individuallyCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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Pongpruttipan et al. Diagnostic Pathology 2014, 9:162 Page 2 of 7
http://www.diagnosticpathology.org/content/9/1/162review 117 lymphoma cases in order to determine the
variation in classifying lymphomas. The results of the
present study may be useful for hematologists and
hematopathologists alike to aware common diagnostic
pitfalls.
Methods
This study was approved by Institutional Review Board
of each institution participating in the study, including
Faculty of Medicine Siriraj Hospital, Mahidol University,
Faculty of Medicine, Chulalongkorn University, Faculty
of Medicine, Chiang Mai University, and Faculty of
Medicine, Prince of Songkhla University.
The studied cases were recruited from cases with
original diagnoses of Hodgkin and non-Hodgkin lymph-
omas. Mycosis fungoides was excluded from the study.
A hundred and nineteen cases were randomly recruited
from 4 institutions, but 2 cases were excluded due
to inadequate material, thus 117 remained (58 from
Chulalongkorn Hospital, 48 from Siriraj Hospital, 8 from
Songkhla University Hospital, and another 8 Chiang Mai
University Hospital). The cases were selected consecu-
tively, regardless of lymphoma subtypes. Each case was
originally diagnosed by either general pathologists or
hematopathologists of each institute. All the original
diagnoses were made mainly based on evaluation of
Hematoxylin and Eosin (H&E) in conjunction with im-
munohistochemistry (IHC) slides. Some cases also had
additional studies, such as EBV-encoded small RNA
(EBER) in situ hybridization, kappa and lambda im-
munoglobulin light chain in situ hybridization, T-cell
receptor gene and/or immunoglobulin heavy chain gene
rearrangement analysis.
There were 7 hematopathologists, members of the
“Thai Hematopathologist Group”, participating to re-
view the cases. We set up two days for meeting. On the
first day, there was a 6-hour period for each participant
to individually review all 117 cases that provided only
H&E, IHC and in situ hybridization slides. All of clin-
ical data, original diagnoses and pathological reports
were not given. Skipping cases without giving diagnosis
was not permitted. On the second day of meeting, dis-
cussion and consensus on cases with discordance were
conducted by all hematopathologists, using micro-
scope with real-time video projector. Each diagnosis
given by participants was categorized into 4 categories
toward its consensus diagnosis (Table 1). Difficult
cases were defined as cases with ≥40% of discordance
among participating hematopathologists. Of the 117
cases, 4 were initially unable to make the consensus.
After the meeting, additional immunohistochemical
staining with or without EBER in situ hybridization
were performed and the consensus diagnoses were
reached.Kappa statistics of the five most common lymphoma
subtypes of each pathologist was also analyzed.
Results
Within a 6-hours period given, hematopathologists had
variably speeds in reviewing slides, ranged from 56–117
cases (Table 2). All consensus diagnoses were lymph-
omas. In detail, for the 4 cases that consensus diagnoses
were not reached initially, 2 were diffuse large B-cell
lymphoma (DLBCL) which required additional IHC for
distinguishing from Burkitt lymphoma (BL), while other
2 were extranodal NK/T-cell lymphoma, nasal type
(ENKTL) which required additional IHC and EBER in
situ hybridization for diagnostic confirmation.
When compared to the consensus diagnoses, each
participant had a similar percentage of concordances,
ranging from 84-92% with 86% in average (Table 2).
The average frequencies of minor, major, and serious
discordances were 10%, 3.5% and 0.3%, respectively
(Table 2). Frequencies of each lymphoma subtype and
their frequencies of discordances were shown in
Table 3.
Five most common lymphomas in the present study
were DLBCL, follicular lymphoma (FL), extranodal mar-
ginal zone lymphoma of mucosa-associated lymphoid
tissue (MALT lymphoma), nodular sclerosis classical
Hodgkin lymphoma (NSCHL), and ENKTL. For DLBCL,
about half of the discordances were BL while one-third
was FL. For MALT lymphoma, 7/8 of discordances were
various small B-cell lymphoma subtypes, while the other
was “DLBCL versus FL”. For FL, 5/9 of discordances
were associated with other small B-cell lymphoma
subtypes, particularly with nodal marginal zone B-cell
lymphoma (NMZL), while 4/9 were debated with
DLBCL or with accompanying DLBCL. In addition, 3
out of 7 FLs were small incisional biopsies which had
significantly higher discordances when compared to the
excisional cases (7/9 vs. 2/19, p = 0.02). For NSCHL, all
discordances were debated on its various subtypes.
The difficult cases, defined by using the aforemen-
tioned criteria, accounted for 16% (19/117) of all cases
were demonstrated in details in Table 4. Of interest,
these difficult cases accounted for 71% of all discor-
dances made.
Compared to the consensus diagnoses, 6% (7/117) of
original diagnoses were with minor discordance and 5%
(6/117) with major discordance (Table 3). No original
diagnosis with serious discordance was found. Among
the 13 cases with discordant original diagnoses, 11 of
them (85%) also had high discordant rate, fulfilling the
criteria of “difficult cases”.
In the present study, cases with “serious discordance”
were rare. One out of 2 was a NMZL that was misdiag-
nosed as lymph node with marginal zone hyperplasia by
Table 1 Definition of each diagnostic category made by hematopathologists when compared to the consensus
diagnosis
Category Description
1. Concordance Hematopathologist made a single diagnosis, identical to the consensus diagnosis
2. Minor discordance Hematopathologist made >1 diagnoses, and one of the given differential diagnoses met the consensus diagnosis;
or discordance between classical Hodgkin lymphoma subtypes
3. Major discordance Hematopathologist made ≥1 diagnosis(es) of lymphoma, but not any of given diagnosis met the consensus diagnosis
4. Serious discordance Hematopathologist made a diagnosis of reactive process, disagreed to the consensus diagnosis of lymphoma
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lymphoma, not otherwise specified (PTCL, NOS) that
was misdiagnosed as atypical lymphoid hyperplasia.
The kappa statistics of the five most common
lymphoma subtypes for each pathologist were shown in
Table 5. The overall kappa statistics for DLBCL, FL,
MALT lymphoma, NSCHL and ENKTL were 0.90, 0.80,
0.84, 0.75 and 0.74, respectively.
Discussion
Similar to the present study, other studies also re-
ported a common interobserver variation in classifying
lymphomas using other classifications or by various
ways [4-7]. The overlapping features among lymphoma
subtypes together with either interobserver or inter-
institutional variation inevitably lead to discordance
[8-10]. In the current WHO classification (2008),
many subtypes of lymphomas use mostly the same
criteria as those described in the 2001 version, while
some underwent critical changes (such as grade 3 FL).
Certainly, some new entities were introduced to the
current 2008 version. Generally, effort to classify into
more subtypes with detail in criteria should reduce
discordant diagnoses. Nevertheless, in practical, dis-
cordance in diagnosis still exists and may be due to
the frequent overlapping features in many subtypes. A
recent study showed an evidence of decreased discord-
ant rate. The authors hypothesized that this may be
due to more experience of the pathologists in applying
the WHO classification [11].Table 2 Number of reviewed cases and percentage in each di
H
A B C
Numbers of reviewed casesb 117 105 56
Category of diagnosesc (%)
1. Concordance 84 84 86
2. Minor discordance 13 12 9
3. Major discordance 3 4 5
4. Serious discordance 0 0 0
aSeven hematopathologists were blindly coded as A to G.
bNumbers of reviewed cases are numbers of cases that each hematopathologist co
cPlease see the description of each diagnostic category in Table 1.Distribution of each lymphoma subtype in the present
study was similar to the previous study of Thai lymph-
omas [12]. This suggests a relatively well random
selection of cases. There were some limitations on the
present study as follow: 1) Only a 6-hours period might
remarkably limits participants to diagnose 117 cases
very carefully, although they were not forced to review
all persisting cases; 2) Lacking of giving clinical informa-
tion might diminish accurate diagnosis in some cases; 3)
All participants knew that all recruited cases were origin-
ally diagnosed lymphoma, hence less chance for making
diagnosis of reactive process; and 4) No results of ancillary
studies were provided to the participants.
The present study gave all available slides to the
participants, so it is somewhat similar to a process in
reviewing pathological diagnosis, except for lacking of
provided original diagnosis, clinical information and
other ancillary studies. However, the aim of the present
study is mainly concentrated to the interobserver vari-
ation among hematopathologists. As shown in the re-
sults, discordances between the original diagnosis and
consensus diagnosis were slightly less than the average
of those made by participants, which may be due to the
aforementioned limitations.
From each participant, overall discordance of any cat-
egories ranged from 8-16%. Almost all were minor and
major discordances. The summation of these 2 categor-
ies was relatively similar among participants. However, it
is not obviously related to the participants’ reviewing
speeds. These may reflect the personal confidence inagnostic category of each hematopathologist
ematopathologista Average
D E F G
94 88 114 81 94 (80%)
92 90 84 85 86
6 7 14 6 10
2 3 1 7 3.5
0 0 1 1 0.3
uld individually review within a 6-hours period.
Table 3 Summary of discordance for each lymphoma subtype made by all hematopathologists
Consensus diagnosis Overallfrequency (%)
Category of diagnosesa (%)
Concordance Minor discordance Major discordance Serious discordance
Diffuse large B-cell lymphoma 68 (58) 93 4 3 0
Follicular lymphoma 7 (6) 77 20 3 0
MALT lymphoma 6 (5) 79 12 9 0
Nodular sclerosis classical HL 6 (5) 81 19 0 0
Extranodal NK/T-cell lymphoma 5 (4) 65 23 12 0
Nodal marginal zone lymphoma 3 (3) 72 16 6 6
Mixed cellularity classical HL 3 (3) 59 41 0 0
Mantle cell lymphoma 3 (3) 100 0 0 0
Peripheral T-cell lymphoma, NOS 3 (3) 75 13 6 6
Angioimmunoblastic T-cell lymphoma 2 (2) 90 10 0 0
Anaplastic large cell lymphoma 2 (2) 91 0 9 0
T lymphoblastic lymphoma 2 (2) 78 22 0 0
Lymphoplasmacytic lymphoma 2 (2) 18 55 27 0
Classical HL 1 (1) 100 0 0 0
Lymphocyte-rich classical HL 1 (1) 33 67 0 0
Marginal zone/lymphoplasmacytic lymphomab 1 (1) 100 0 0 0
Subcutaneous panniculitis-like T-cell lymphoma 1 (1) 100 0 0 0
Cutaneous T-cell lymphoma, unclassified 1 (1) 75 25 0 0
Average 86 10 3.5 0.3
aPlease see the description of each diagnostic category in Table 1.
bA CD5-/CD10-/cyclin D1- small B-cell neoplasm with plasmacytic differentiation in a bone marrow biopsy which definite subtype could not be classified.
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to make the most likely single diagnosis or some
preferred to include multiple differential diagnoses. A
recent study that used WHO classification showed 9%
discordant rate, lower than the present study. This may
be caused by several factors including the aforemen-
tioned limitation as well as the methodological differ-
ences, for example, the former study grouped all T- and
NK-cell lymphomas into a single category [11].
In the present study, only viewpoints upon discordances
among the five most lymphoma subtypes was discussed.
Among the five most common lymphomas, DLBCL had
the highest concordance. Similar results among general
pathologists have been documented [7,13]. In the present
study, cases with discordance between DLBCL and BL
may represent the unclassifiable B-cell lymphoma with
intermediate features between DLBCL and BL in the 2008
WHO classification (2008) [14]. Grade 3 FL with any obvi-
ous diffuse growth pattern should be classified as DLBCL
in the WHO classification [15]; however, some cases in
the present study might have vague diffuse areas leading
to diagnostic discordance. Fortunately, treatment for grade
3 FL and DLBCL is similar. In grade 3b FL, the neoplastic
cells may express IRF4/MUM1 but not CD10 [16]. Other
than CD10 and BCL6, HGAL might be a new sensitive
marker for germinal center phenotype [17]. Furthermore,in small biopsies, it is a limitation for complete evaluation
of nodular architecture, especially in cases with very large
irregular neoplastic nodules. IHC markers will be helpful
to highlight large neoplastic cells growing in follicular
dendritic meshworks in order to reach the diagnosis of
this particular FL.
A relatively high rate of discordance in making diagnosis
of MALT lymphoma has been reported [6,7]. In the
present study, the discordance was raised because partici-
pants mainly included other small B-cell lymphomas for
differential diagnoses. Although almost cases generally
lack of CD5 expression, a small subset of MALT lymph-
oma may express CD5 [18,19]. This may potentially in-
crease discordance rate. Interestingly, one common pitfall
is a misdiagnosis of MALT lymphoma with increased scat-
tered large cells as DLBCL [7], that will be concerned as a
significant therapeutic alteration. Only cases with definite
confluent sheet of large B-cells should be diagnosed as
DLBCL, either de novo or histologic transformed case
[20]. And it has been documented that high proliferative
index by using Ki67 is useful for distinguishing gastric
DLBCL from gastric MALT lymphoma [21].
In the present study, FL cases with small incisional
biopsies showed significantly higher discordances than
those with excisional biopsies. Therefore, making diag-
nosis on cases with small incisional biopsy should be
Table 4 Details of the difficult casesa
Case no. Consensus diagnosis Discordance of theoriginal diagnosisb
Frequency of each diagnostic categoryc
Concordance Minor discordance Major discordance Serious discordance
86 MALT lymphoma Minor 0 2 3 0
101 Extranodal NK/T-cell lymphomad Major 0 1 3 0
19 Diffuse large B-cell lymphomad - 4 0 3 0
83 Lymphoplasmacytic lymphoma Minor 0 2 2 0
32 Diffuse large B-cell lymphoma - 3 0 2 0
82 Lymphoplasmacytic lymphoma Minor 2 4 1 0
113 Peripheral T-cell lymphoma, NOS Major 1 2 1 0
78 Follicular lymphoma - 3 2 1 0
36 Diffuse large B-cell lymphoma - 0 5 0 0
100 Extranodal NK/T-cell lymphomad Minor 0 5 0 0
93 Mixed cellularity classical HL Minor 1 5 0 0
76 Follicular lymphoma - 3 4 0 0
109 Nodular sclerosis classical HL Major 3 4 0 0
98 Nodal marginal zone lymphoma - 3 3 0 0
84 Lymphocyte-rich classical HL Minor 1 2 0 0
91 Mixed cellularity classical HL Minor 3 2 0 0
62 Diffuse large B-cell lymphomad - 3 2 0 0
116 T lymphoblastic lymphoma - 3 2 0 0
23 Diffuse large B-cell lymphoma - 1 1 0 0
Total 23 30 11 0
aDifficult cases were cases that at least 40% of hematopathologists (participants) made discordant diagnoses.
bOriginal diagnoses, initially made by attending pathologists in clinical services, were also categorized into 4 categories by comparing to the consensus diagnoses.
Blanks represent “concordance”.
cPlease see the description of each diagnostic category in Table 1.
dCases that consensus diagnoses could not be reached at the initial meeting and additional investigations were performed before reaching the
consensus diagnoses.
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discordances were mostly associated with other small
B-cell lymphoma subtypes; while the high-grade FL was
mostly debated between DLBCL as mentioned above.
For NSCHL, particularly those with small biopsies,
distinctions between its subtypes were difficult and sub-
jective. Although there are common discordances among
subtyping of classical Hodgkin lymphoma, management
among the subtypes is the same.
Although EBV positivity is characteristic and specific for
ENKTL than other T-cell lymphoma subtypes [22,23], the
discordance for ENKTL was relatively high in the presentTable 5 Kappa statistics of the five most common lymphoma
Kappa statistic
A B C
Diffuse large B-cell lymphoma 0.93 (68) 0.88 (60) 0.85 (38)
Follicular lymphoma 0.82 (7) 0.75 (6) 0.45 (3)
MALT lymphoma 0.90 (6) 0.65 (6) 0.79 (3)
Nodular sclerosis classical HL 0.90 (6) 0.90 (6) 0 (1)
Extranodal NK/T-cell lymphoma 0.74 (5) 0.85 (4) 1.00 (3)study because 2/5 cases (originally reported as PTCL,
NOS and PTCL, NOS versus ENKTL) had no prior EBV
studies; so participants included at least 2 differential
diagnoses. EBER in situ hybridization was subsequently
performed following the consensus, and both cases were
positive. Study for EBV is essential for ENKTL, since
ENKTL is common NK- and T-cell lymphomas in many
Asian countries including Thailand [24,25]. Further-
more, ENKTL may be of either αβ or γδ T-cell lineage
[26], and requires different chemotherapy regimens
[27-29], as well as benefits from radiation plus therapy
[26,27]. Thus, evidence of EBV association by usingsubtypes of each hematopathologist
s of each hematopathologist (n)
Average
D E F G
0.96 (57) 0.95 (47) 0.93 (66) 0.92 (50) 0.92
0.88 (5) 0.92 (7) 0.82 (7) 0.79 (5) 0.80
0.90 (6) 1.00 (4) 0.90 (6) 1.00 (2) 0.84
0.90 (6) 0.92 (6) 0.65 (6) 1.00 (2) 0.75
1.00 (3) 0.49 (3) 0.74 (5) 0.49 (1) 0.74
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positive mature lymphomas. EBV LMP1 and LMP2 im-
munohistochemistry is positive in some proportion of
cases [30], but is not a sensitive test.
Lymphoplasmacytic lymphoma, when without available
clinical correlation, was one of lymphomas with a very
high discordance rate as shown in this study. This may be
due to the lack of specific morphologic and immunophe-
notypic features but with many overlapping features with
other small B-cell neoplasms with plasmacytic differenti-
ation, particularly marginal zone lymphomas with plasma-
cytic differentiation. Characteristic cytogenetic findings of
marginal zone lymphoma, if present, might be a useful
feature for dissolving of this issue.
Conclusion
There are some degrees of interobserver variation in
classifying of lymphoma by using the 2008 WHO clas-
sification. The uncommon discordances showed in the
present study are similar to the previously published
studies. The overlapping in morphologic, immunophe-
notypic and genetic features among various lymphoma
subtypes may cause uncommon discordances in classi-
fying lymphomas. Awareness of the overlapping fea-
tures as well as the common pitfalls might be helpful
for reducing discordances among pathologists and
hematologists. Some lymphoma subtypes on small
biopsies were found to have a significant higher dis-
cordance rate, particularly for those which needs archi-
tectural evaluation.
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